Please login to the form below

Not currently logged in
Email:
Password:

Vintura appoints Lieven Annemans as an associate partner

He will advise the consultancy's clients on market access issues

Lieven AnnemansHealthcare and life sciences consultancy firm Vintura has appointed health-economics professor Lieven Annemans as an associate partner after previously working with him in health-economic areas.

His new role will see him advise international life sciences organisations with market access challenges.

Bas Amesz, partner at Vintura, said: “Lieven adds valuable knowledge and international experience in the areas of health-economics and value-based healthcare.

“Furthermore, Lieven is also a valuable addition to our team, he is an inspiring ‘thought leader’ with a no-nonsense work ethic and a pleasure to work with.”

The professor teaches in the faculty of medicine and health sciences at Ghent University based in Belgium and he is also president of the Flemish Healthcare council.

“By joining forces with Lieven we will increase our ability to create meaningful impact in healthcare by advising and supporting healthcare organisations, industry and government.

“This way we will jointly contribute to the realisation of universal and equitable access of patients to new therapies.”

Annemans has served in a variety of roles including president of the Internation Society for Pharmaeconomics and Outcomes Research (ISPOR), former cabinet advisor to secetary Frank Vandenbroucke and is the laureate of the Francqui chair in 2013 and 2016.

10th July 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...